Details for Patent: 9,040,074

✉ Email this page to a colleague

Which drugs does patent 9,040,074 protect, and when does it expire?

Patent 9,040,074 protects JELMYTO and is included in one NDA.

This patent has nine patent family members in six countries.

Summary for Patent: 9,040,074

Title:	Material and method for treating internal cavities
Abstract:	A hydrophilic biocompatible sustained-release material is disclosed. The material comprises amounts of Pluronic F-127, PEG-400, HPMC and water, effective to produce a composition of sufficiently low viscosity at room temperature to be injectable into an internal body cavity via a tube inserted within a urinary catheter. At body temperature, the material exhibits a much higher viscosity and will stably adhere to the internal surface of a body cavity. As the material dissolves, a therapeutic agent incorporated therein is slowly released to the body cavity, while the material itself is excreted from the body.
Inventor(s):	Holzer; Asher (Raanana, IL), Daniel; Dorit (Raanana, IL), Mullerad; Michael (Tel Aviv, IL), De La Zerda; Jaime (Haifa, IL), Shpolansky; Uri (Pardes Hana, IL), Malchi; Nadav (Pardes Hanna-Karkur, IL), Dollberg; Yosh (Raanana, IL), Tal; Dor (Hadera, IL), Yavin; Yossi (Mikhmoret, IL), Konorty; Marina (Hertzyla, IL)
Assignee:	Theracoat Ltd. (Ra'anana, IL)
Application Number:	13/553,198
Patent Claim Types: see list of patent claims	Use; Composition; Compound; Dosage form;

Drugs Protected by US Patent 9,040,074

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Urogen Pharma	JELMYTO	mitomycin	POWDER;PYELOCALYCEAL	211728-001	Apr 15, 2020		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

International Family Members for US Patent 9,040,074

Subscribe to access the full database, or Sign Up
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Germany	212011100034	⤷ Sign Up
Denmark	2525777	⤷ Sign Up
European Patent Office	2525777	⤷ Sign Up
European Patent Office	2734187	⤷ Sign Up
Spain	2732150	⤷ Sign Up
Israel	221040	⤷ Sign Up
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.